Align Technology Inc (ALGN) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Align Technology Inc (ALGN) stock forecast summary
On Oct. 16, 2026, ALGN is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Align Technology Inc is a large-cap company with a market capitalization of $10.46B. It ranks number 5 by market capitalization among the 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For ALGN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ALGN included.
Follow ALGN freeALGN price chart and AI forecast
How ALGN ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Align Technology Inc (ALGN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Valuation & Market
| Metric | ALGN | Rank |
|---|---|---|
| Market Cap | $10.46B | 5/27 |
| P/E Ratio | 25.66x | 4/9 |
| P/B Ratio | 2.47x | 10/22 |
| EPS | $5.74 | – |
| Book Value/Share | $59.58 | – |
| Revenue/Share | $58.27 | – |
| FCF/Share | $8.92 | – |
Profitability & Margins
| Metric | ALGN | Rank |
|---|---|---|
| ROE | 9.8% | 5/19 |
| ROA | 6.4% | 4/19 |
| ROIC | 12.1% | 6/22 |
| Gross Margin | 68.0% | 7/20 |
| Operating Margin | 13.2% | 5/21 |
| Net Margin | 10.0% | 4/17 |
| EBT Margin | 13.7% | 4/21 |
| Tax Rate | 27.3% | – |
Financial Health
| Metric | ALGN | Rank |
|---|---|---|
| Current Ratio | 1.40x | 23/25 |
| Quick Ratio | 1.28x | 17/22 |
| D/E Ratio | 0.52x | 16/24 |
| Financial Leverage | 1.52x | 16/24 |
| Interest Coverage | 518.2x | 2/21 |
| Working Capital | $754M | 5/25 |
Cash Flow
| Metric | ALGN | Rank |
|---|---|---|
| Operating Cash Flow | $756M | 5/25 |
| Free Cash Flow | $634M | 3/16 |
| Capital Spending | -$122M | 13/16 |
| OCF Growth YoY | 3.4% | 9/10 |
| FCF Growth YoY | 0.3% | 7/7 |
| FCF/Sales | 15.3% | 4/16 |
| CapEx/Sales | 3.0% | 5/16 |
Operational Efficiency
| Metric | ALGN | Rank |
|---|---|---|
| Asset Turnover | 0.65x | 11/18 |
| Receivables Turnover | 3.6x | 14/17 |
| Inventory Turnover | 6.2x | 3/22 |
| Fixed Assets Turnover | 3.7x | 13/19 |
| Days Sales Outstanding | 101 days | 4/17 |
| Days Inventory | 59 days | 20/22 |
| Payables Period | 30 days | 17/19 |
| Cash Conversion Cycle | 130 days | 10/15 |
Income Statement
| Metric | ALGN | Rank |
|---|---|---|
| Total Revenue | $4.14B | 3/19 |
| Operating Income | $548M | 5/25 |
| Net Income | $414M | 4/19 |
| R&D Expense | $377M | 4/22 |
| SG&A Expense | $1.79B | 4/22 |
| Cost of Goods Sold | $1.32B | 5/22 |
Dividend & Shareholder Information
| Metric | ALGN | Rank |
|---|---|---|
| Shares Outstanding | 71M | – |
| Net Income Growth | -5.5% | 7/7 |
| EPS Growth | -3.4% | 7/8 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $2.66B | 41.5% of assets |
| Cash & Short-term Investments | $1.10B | 17.2% of assets |
| Accounts Receivable | $1.15B | 17.9% of assets |
| Inventory | $212M | 3.3% of assets |
| Total Liabilities | $2.19B | 34.0% of assets |
| Short-term Debt | $1.80B | 28.0% of assets |
ALGN quarterly financials and insider trading
Align Technology Inc (ALGN) industry peers
Companies classified under the same SEC industry code as Align Technology Inc (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ALGN Align Technology Inc | ▶ | $10.46B |
| ISRG Intuitive Surgical Inc | ▼ | $150.74B |
| STE Steris Plc | ▼ | $21.71B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $18.12B |
| SNN Smith & Nephew Plc | ▼ | $12.75B |
| MSA Msa Safety Inc | ▼ | $6.91B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.76B |
| ENOV Enovis Corp | ▶ | $1.13B |
| CDRE Cadre Holdings, Inc. | ▼ | $1.13B |
| AVR Anteris Technologies Global Corp. | ▶ | $590M |
| SMTI Sanara Medtech Inc. | ▼ | $305M |
| INGN Inogen Inc | ▲ | $166M |
| LAKE Lakeland Industries Inc | ▲ | $90M |
| NTRB Nutriband Inc. | ▲ | $76M |
| APT Alpha Pro Tech Ltd | ▲ | $57M |
| COCH Envoy Medical, Inc. | ▼ | $52M |
| MYO Myomo, Inc. | ▲ | $48M |
| MLSS Milestone Scientific Inc. | ▲ | $29M |
| LFWD Lifeward Ltd. | ▲ | $17M |
| UEEC United Health Products, Inc. | ▲ | $14M |
| CUPR Cuprina Holdings (Cayman) Ltd | ▶ | $13M |
| RGNT Regentis Biomaterials Ltd. | ▶ | $10M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $7M |
| LGMK Logicmark, Inc. | ▲ | $1M |
| BBLG Bone Biologics Corp | ▲ | $1M |
| RBOT Vicarious Surgical Inc. | ▼ | $550K |
| FEED Envue Medical, Inc. | ▼ | $340K |
Where ALGN sits on the market map
Align Technology Inc (ALGN) stock news
Loading...
Align Technology Inc (ALGN) stock forecast FAQ
What is the Align Technology Inc (ALGN) stock forecast?
On Oct. 16, 2026, ALGN is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Align Technology Inc stock predictions?
For ALGN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 3.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Align Technology Inc forecasts updated?
Align Technology Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Align Technology Inc's industry peers?
27 issuers in our coverage, ALGN included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Msa Safety Inc (MSA), Establishment Labs Holdings Inc. (ESTA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.